Ethacrynic acid is a well-known loop diuretic that has been used in clinical practice for several decades. Marketed under trade names such as Edecrin and Sodium Edecrin, this medication is primarily employed to manage
edema associated with
congestive heart failure,
liver disease, and
kidney disorders. Ethacrynic acid stands out from other loop diuretics like
furosemide and
bumetanide because it is not a sulfonamide, making it a viable option for patients who are allergic to sulfa drugs.
The drug was first discovered and developed in the mid-1960s and has since been extensively studied. Research institutions around the world have delved into various aspects of ethacrynic acid, from its pharmacodynamics to its long-term efficacy and safety profiles.
Ethacrynic acid is primarily indicated for patients with edema that has proven resistant to other forms of diuretic therapy. It is sometimes used off-label to treat
high blood pressure, although this is less common. The drug has also been investigated for its potential anticancer properties due to its ability to inhibit glutathione S-transferase, an enzyme involved in cellular detoxification and apoptosis.
### Ethacrynic Acid Mechanism of Action
Ethacrynic acid exerts its diuretic effect by inhibiting the
Na-K-2Cl (sodium-potassium-chloride) cotransporter in the thick ascending limb of the loop of Henle in the kidneys. This action results in the loss of sodium, chloride, and water, which leads to a decrease in the volume of extracellular fluid. As a result, there is a reduction in blood pressure and a decrease in edema.
Unlike other loop diuretics, ethacrynic acid does not contain a sulfonamide moiety. This unique chemical structure renders it useful for patients who have allergies to sulfonamide-based drugs. Ethacrynic acid's ability to inhibit the Na-K-2Cl cotransporter is dose-dependent, and its potency is comparable to that of other loop diuretics.
In addition to its diuretic effects, ethacrynic acid has been shown to inhibit glutathione S-transferase, which is significant in
cancer research. This enzyme plays a role in the detoxification of carcinogens and the regulation of cell death. By inhibiting this enzyme, ethacrynic acid may enhance the efficacy of certain chemotherapy agents, although this application is still under investigation.
### How to Use Ethacrynic Acid
Ethacrynic acid is available in both oral and intravenous formulations. The oral form is typically used for outpatient management of chronic conditions, while the intravenous form is reserved for acute settings, such as hospital admissions for severe edema or heart failure exacerbations.
For oral administration, the initial dose for adults usually ranges from 50 to 100 mg per day, taken in divided doses. The dosage may be adjusted based on the patient's response and tolerance, with a typical maintenance dose ranging from 25 to 100 mg per day. The maximum recommended daily dose is 200 mg.
Intravenous administration is initiated at a dose of 50 mg, given slowly over several minutes to avoid rapid fluid shifts that can lead to complications. The onset of action for intravenous ethacrynic acid occurs within 5 to 15 minutes, while the oral form takes about 30 to 60 minutes to start working. The duration of action for both forms is approximately 6 to 8 hours.
Patients are advised to take ethacrynic acid with food to minimize gastrointestinal discomfort. It's crucial to monitor electrolyte levels, kidney function, and blood pressure regularly while on this medication, as it can cause significant fluid and electrolyte imbalances.
### What are Ethacrynic Acid Side Effects
Like any medication, ethacrynic acid has a range of potential side effects. The most common ones include
electrolyte imbalances (such as
hyponatremia,
hypokalemia, and
hypomagnesemia),
dizziness,
dehydration, and gastrointestinal disturbances like nausea and vomiting. These side effects are generally dose-dependent and can be mitigated by careful monitoring and dose adjustment.
More serious but less common side effects include
ototoxicity, which can manifest as
hearing loss or
tinnitus, especially at high doses or when administered intravenously. This risk is higher in patients with pre-existing kidney
dysfunction or those taking other ototoxic drugs.
Contraindications for ethacrynic acid include
anuria (the inability to produce urine), severe electrolyte imbalances, and hypersensitivity to the drug. Caution is advised in patients with liver disease, as rapid fluid and electrolyte shifts can precipitate
hepatic encephalopathy.
Ethacrynic acid is classified as a pregnancy category C drug, meaning that it should only be used if the potential benefits justify the potential risks to the fetus. It is also excreted in breast milk, so nursing mothers should use this medication with caution.
### What Other Drugs Will Affect Ethacrynic Acid
Ethacrynic acid can interact with a variety of other medications, leading to either increased toxicity or reduced efficacy. Concomitant use with other diuretics can potentiate the risk of electrolyte imbalances and dehydration. Nonsteroidal anti-inflammatory drugs (NSAIDs) can blunt the diuretic effect of ethacrynic acid and increase the risk of nephrotoxicity.
Other drugs that can interact with ethacrynic acid include aminoglycoside antibiotics, which can exacerbate ototoxicity, and corticosteroids, which can increase the risk of hypokalemia.
Lithium levels can be increased when used concurrently with ethacrynic acid, leading to potential lithium toxicity.
It's essential to review all medications, including over-the-counter drugs and supplements, with a healthcare provider to identify and manage potential drug interactions effectively.
In conclusion, ethacrynic acid is a valuable loop diuretic with unique properties that make it suitable for specific patient populations. While it offers robust diuretic effects, careful monitoring and management are crucial to minimize potential side effects and drug interactions. Ongoing research continues to explore its full therapeutic potential, particularly in oncology.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


